‘There’s a real attack on the industry’: Medical marijuana sales continue to drop in Colorado
ColoradoMarijuana Industry NewsMedical MarijuanaRecreational Marijuana September 5, 2022 MJ Shareholders 0
Colorado’s Department of Revenue says medical marijuana sales are continuing to drop.
Experts are worried about people with health conditions having access to the treatment they need. They say patients are paying more in taxes for similar products at recreational facilities.
“This is the lowest they’ve been since the legalization of recreational. I’m very worried,” said Truman Bradley.
Worried is an understatement for Truman Bradley, executive director of the Marijuana Industry Group, a trade association in Colorado that provides support for marijuana-related businesses. He believes in safe access to clean products for all Coloradans and its visitors.
According to the Colorado Department of Revenue, medical marijuana sales in the state in June 2022 were $19.2 million, down from $34.5 million in June 2021 — a 44% drop. Bradley believes the industry is suffering for a number of reasons.
“On the medical side, some very strict purchase limits came in, you know, for pharmaceuticals. Patients can get up to a one-month supply. But for medical cannabis, their daily purchase limits for folks who are immunocompromised or disabled, this is a real problem,” he said.
Bradley says this is making some patients resort to buying recreational marijuana, which costs more due to the higher tax base and pushes some medical marijuana businesses to shut their doors. Buddy Boy dispensaries and Mile High Green Cross closed their locations over the last few months.
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.